Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes
The regulatory uncertainty bothers many reviewers
In studies, tested doses were: 1 mg 4 mg 8 mg 12 mg weekly (maximum) While the exact dosing plan for retatrutide isnt finalized yet, the overall pattern should feel familiar
Based on typical FDA review timelines and the current progress of trials, analysts project: Phase 3 trial completion: Late 2025 to early 2026 FDA submission: First half of 2026 Potential FDA approval: Q3 2026 to Q1 2027 Commercial availability: 2-3 months post-approval The FDA has not granted any special designations (Breakthrough Therapy, Fast Track) for Retatrutides obesity indication, which may mean standard review timelines apply
Copyright 2026 WSAW
When combined with a calorie-controlled diet and consistent training, this may support small improvements in body composition
